Ethyl gallate
Ethyl gallate obviously decreases cell proliferation in MDA-MB-231 and MCF-7 cells in a dose- and time-dependent manner, exhibits cytotoxicity in a dose-dependent manner. Ethyl gallate can inhibit the abilities of invasion of breast cancer in vitro by inhibiting the mRNA levels of MMP-9/MMP-2, phosphorylation of Akt and protein expression of NF-κB and inhibits hydrogen peroxide signaling, may represent an alternative class of vasopressors for use in septic shock. Also, Ethyl gallate suppresses proliferation and invasion in human breast cancer cells by modulating the PI3K/Akt pathway, which may contribute to inhibiting their downstream targets such as NF-κB p-65, Bcl-2/Bax, and mRNA levels of MMP-2 and MMP-9 in breast cancer cells, could be used as potential antioxidants with safe therapeutic application in cancer chemotherapy.

Catalog Number | T3729 |
Alternative Name(s) | Nipagallin A , Phyllemblin , gallic acid ethyl ester |
Research Area | Cytoskeletal Signaling|||PI3K/Akt/mTOR signaling|||Microbiology/Virology|||Proteases/Proteasome|||NF-Κb |
Molecular Formula | C9H10O5 |
CAS# | 831-61-8 |
Purity | 99.58% |
SMILES | CCOC(=O)c1cc(c(c(c1)O)O)O |
Size | 100 mg |
Supplier Page | https://www.targetmol.com/compound/Ethyl gallate |
Additional Information | https://www.targetmol.com/datasheet/T3729 |